image_pdfimage_print

Remicade® Therapy

Breakthrough treatment for Crohn’s disease, ulcerative colitits and rheumatoid arthritis.

One of the most effective medications available for patients with Crohn’s disease, ulcerative colitis, and rheumatoid arthritis is Remicade (infliximab), which is FDA-approved for these conditions. Remicade works by blocking your immune system’s overproduction of a protein called TNF-alpha, a main cause of inflammation. Remicade targets and neutralizes TNF-alpha, which relieves the inflammation that can cause a whole host of painful symptoms in people with Crohn’s disease, ulcerative colitis and rheumatoid arthritis.  Remicade is administered via intravenous (IV) infusion.

Remicade, Crohn’s disease and Ulcerative Colitis.

Crohn’s disease and ulcerative colitis are chronic inflammation of the intestine that have no medical cure. These diseases affect about one to five people per 10,000 in the United States. Symptoms of these diseases include chronic diarrhea, fatigue, low-grade fever, unexplained weight loss, abdominal cramps, joint pain and skin lesions. Remicade has been clinically proven to reduce the signs and symptoms of Crohn’s disease and Ulcerative Colitis as well as achieve remission.

In addition, Remicade has helped patients lower their anti-inflammatory dosages and steroid usage and, in some cases, eliminated the need for them altogether.

Remicade and Rheumatoid Arthritis.

Rheumatoid arthritis is the most debilitating form of arthritis and can develop between ages 20 and 50. Symptoms include pain and swelling in the joints of the hands and feet and overall aching and stiffness. In patients with rheumatoid arthritis, Remicade has been clinically proven to reduce signs and symptoms, prevent the progression of structural damage and improve overall physical function.

Office Infusion Center.

In 1998, Dr. Barry D. Winston began in-office infusion therapy to provide patients with an office-based alternative to hospital-based infusions.  Infusion therapy visits normally last between 2-3 hours.

Your infusion therapy will take place inside a spacious, private room. The infusion center affords many comforts that can make your experience a positive one.  When patients arrive for treatment, they are evaluated prior to infusion therapy to determine the accurate dosage of Remicade.  During the infusion patients vital signs are carefully monitored by our highly trained staff.

For more information on Remicade therapy, please contact your doctor or call us a 281-440-3618 today.